Endocannabinoids Released in the Ventral Tegmental Area During Copulation to Satiety Modulate Changes in Glutamate Receptors Associated With Synaptic Plasticity Processes.
AMPA and NMDA glutamate receptors
CB1 receptors
endocannabinoids
mesolimbic circuit
natural reward
sexual satiety
synaptic plasticity
ventral tegmental area
Journal
Frontiers in synaptic neuroscience
ISSN: 1663-3563
Titre abrégé: Front Synaptic Neurosci
Pays: Switzerland
ID NLM: 101548972
Informations de publication
Date de publication:
2021
2021
Historique:
received:
27
04
2021
accepted:
08
07
2021
entrez:
6
9
2021
pubmed:
7
9
2021
medline:
7
9
2021
Statut:
epublish
Résumé
Endocannabinoids modulate mesolimbic (MSL) dopamine (DA) neurons firing at the ventral tegmental area (VTA). These neurons are activated by copulation, increasing DA release in nucleus accumbens (NAcc). Copulation to satiety in male rats implies repeated ejaculation within a short period (around 2.5 h), during which NAcc dopamine concentrations remain elevated, suggesting continuous neuronal activation. During the 72 h that follow copulation to satiety, males exhibit long-lasting changes suggestive of brain plasticity processes. Enhanced DA neuron activity triggers the synthesis and release of endocannabinoids (eCBs) in the VTA, which participate in several long-term synaptic plasticity processes. Blockade of cannabinoid type 1 receptors (CB1Rs) during copulation to satiety interferes with the appearance of the plastic changes. Glutamatergic inputs to the VTA express CB1Rs and contribute to DA neuron burst firing and synaptic plasticity. We hypothesized that eCBs, released during copulation to satiety, would activate VTA CB1Rs and modulate synaptic plasticity processes involving glutamatergic transmission. To test this hypothesis, we determined changes in VTA CB1R density, phosphorylation, and internalization in rats that copulated to satiety 24 h earlier as compared both to animals that ejaculated only once and to sexually experienced unmated males. Changes in glutamate AMPAR and NMDAR densities and subunit composition and in ERK1/2 activation were determined in the VTA of males that copulated to satiety in the presence or absence of AM251, a CB1R antagonist. The CB1R density decreased and the proportion of phosphorylated CB1Rs increased in the animals that copulated compared to control rats. The CB1R internalization was detected only in sexually satiated males. A decrease in α-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor (AMPAR) density, blocked by AM251 pretreatment, and an increase in the proportion of GluA2-AMPARs occurred in sexually satiated rats. GluN2A- N-methyl-D-aspartate receptor (NMDAR) expression decreased, and GluN2B-NMDARs increased in these animals, both of which were prevented by AM251 pre-treatment. An increase in phosphorylated ERK1/2 emerged in males copulating to satiety in the presence of AM251. Results demonstrate that during copulation to satiety, eCBs activate CB1Rs in the VTA, producing changes in glutamate receptors compatible with a reduced neuronal activation. These changes could play a role in the induction of the long-lasting physiological changes that characterize sexually satiated rats.
Identifiants
pubmed: 34483875
doi: 10.3389/fnsyn.2021.701290
pmc: PMC8416467
doi:
Types de publication
Journal Article
Langues
eng
Pagination
701290Informations de copyright
Copyright © 2021 Rodríguez-Manzo, González-Morales and Garduño-Gutiérrez.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Neurosci. 2003 Mar 15;23(6):2371-82
pubmed: 12657697
Neurobiol Aging. 2012 Mar;33(3):620.e1-8
pubmed: 21459482
J Neurosci. 2008 Mar 19;28(12):2976-90
pubmed: 18354002
Cell Rep. 2015 Sep 29;12(12):1997-2008
pubmed: 26365195
J Neurosci. 2004 Jan 7;24(1):53-62
pubmed: 14715937
Anal Biochem. 1979 Dec;100(2):201-20
pubmed: 393128
Nat Neurosci. 2003 Mar;6(3):231-42
pubmed: 12577062
J Physiol. 2010 Jul 15;588(Pt 14):2589-604
pubmed: 20498231
Pharmacol Biochem Behav. 2016 Nov - Dec;150-151:182-189
pubmed: 27856203
Brain Res. 2013 Dec 6;1541:22-32
pubmed: 24140428
J Neurosci. 2011 Jun 15;31(24):8851-61
pubmed: 21677169
Neuron. 2003 Nov 13;40(4):775-84
pubmed: 14622581
Trends Neurosci. 2007 Mar;30(3):126-34
pubmed: 17275103
Nat Rev Neurosci. 2013 Jun;14(6):383-400
pubmed: 23686171
Reproduction. 2016 Oct;152(4):351-61
pubmed: 27568210
Neuroscience. 2014 Dec 12;282:60-8
pubmed: 24875175
Neurosci Biobehav Rev. 1990 Summer;14(2):217-32
pubmed: 2190121
Urology. 2008 Nov;72(5):1174-8
pubmed: 18468662
Proc Natl Acad Sci U S A. 2020 May 5;117(18):9991-10002
pubmed: 32312805
Science. 2002 Apr 26;296(5568):678-82
pubmed: 11976437
Neurosci Biobehav Rev. 1995 Spring;19(1):19-38
pubmed: 7770195
Annu Rev Physiol. 2007;69:451-82
pubmed: 17037978
Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8384-8
pubmed: 12060781
Pharmacol Rev. 2011 Sep;63(3):461-70
pubmed: 21752875
Eur J Neurosci. 2002 Jun;15(12):2057-61
pubmed: 12099913
Front Mol Neurosci. 2020 Jul 28;13:130
pubmed: 32848596
Neurosci Lett. 1990 Nov 27;120(1):70-3
pubmed: 2293096
J Neurosci. 2009 Feb 11;29(6):1735-42
pubmed: 19211880
Neuropsychopharmacology. 2005 Mar;30(3):508-15
pubmed: 15525997
Behav Brain Res. 1994 Jun 30;62(2):127-34
pubmed: 7945962
J Neurochem. 1999 Aug;73(2):493-501
pubmed: 10428044
Rev Neurosci. 1994 Oct-Dec;5(4):317-29
pubmed: 7697200
Mol Pharmacol. 2016 Nov;90(5):620-626
pubmed: 27338082
J Neurosci. 2012 Feb 1;32(5):1672-86
pubmed: 22302809
J Neurosci. 2015 Apr 15;35(15):6165-78
pubmed: 25878288
Brain Res. 1993 Jul 30;618(1):41-6
pubmed: 8402177
J Neurosci. 2011 Aug 3;31(31):11244-55
pubmed: 21813685
J Neurosci. 2003 Jan 1;23(1):149-57
pubmed: 12514211
Behav Brain Res. 2011 Mar 1;217(2):253-60
pubmed: 20875461
J Neurosci. 2004 Dec 8;24(49):11070-8
pubmed: 15590923
Physiol Behav. 1997 Feb;61(2):285-91
pubmed: 9035260
Neuroscience. 2007 May 25;146(3):1259-74
pubmed: 17391856
Behav Brain Res. 2020 Apr 6;383:112510
pubmed: 31987931
J Neurosci. 2006 Mar 22;26(12):3210-9
pubmed: 16554472
Neuropharmacology. 2008 Jan;54(1):36-44
pubmed: 17681354
PLoS One. 2012;7(4):e34700
pubmed: 22529926
Crit Rev Neurobiol. 2003;15(2):91-119
pubmed: 14977366
FASEB J. 2019 Dec;33(12):14423-14439
pubmed: 31670972
Science. 2007 Jul 27;317(5837):530-3
pubmed: 17656725
J Neurosci. 1997 Jun 15;17(12):4849-55
pubmed: 9169543
Neurobiol Learn Mem. 2016 Nov;135:125-138
pubmed: 27523749
Semin Immunol. 2014 Oct;26(5):380-8
pubmed: 24882055
Eur J Neurosci. 2016 Dec;44(12):2975-2983
pubmed: 27711998
Eur J Neurosci. 2007 Jan;25(1):106-18
pubmed: 17241272
J Neurosci. 2004 May 19;24(20):4859-64
pubmed: 15152046
J Neurosci. 2002 May 1;22(9):3306-11
pubmed: 11978804
Neuron. 2001 Mar;29(3):729-38
pubmed: 11301031
Trends Neurosci. 2002 Nov;25(11):578-88
pubmed: 12392933
Nat Neurosci. 2002 May;5(5):446-51
pubmed: 11976704
Neuropharmacology. 2005 Jun;48(8):1105-16
pubmed: 15878779
Nature. 2001 Mar 29;410(6828):588-92
pubmed: 11279497
Nat Rev Neurosci. 2017 Feb;18(2):73-85
pubmed: 28053327
Eur J Neurosci. 2005 Mar;21(5):1280-8
pubmed: 15813937
Mol Cell Endocrinol. 2013 Jun 15;372(1-2):116-27
pubmed: 23541635
J Neurophysiol. 2009 Aug;102(2):1160-71
pubmed: 19494194
Nature. 2000 May 25;405(6785):454-8
pubmed: 10839540
Neural Regen Res. 2020 Jan;15(1):78-85
pubmed: 31535655
Brain Res Rev. 2007 Nov;56(1):27-78
pubmed: 17574681
J Neurosci. 2010 Jan 6;30(1):218-29
pubmed: 20053904
Front Cell Neurosci. 2014 Nov 27;8:401
pubmed: 25505875
Neuroscience. 2006;137(4):1259-76
pubmed: 16388908
Behav Neurosci. 1992 Feb;106(1):181-91
pubmed: 1313243
Neuron. 2001 Mar;29(3):717-27
pubmed: 11301030
Neuron. 2003 May 8;38(3):461-72
pubmed: 12741992
Front Neurosci. 2018 Mar 05;12:131
pubmed: 29556175
Neuroreport. 2001 Aug 8;12(11):2549-52
pubmed: 11496146
Nat Neurosci. 2015 Mar;18(3):386-92
pubmed: 25664911
Br J Pharmacol. 2004 May;142(1):9-19
pubmed: 15100161
Nat Rev Neurosci. 2007 Jun;8(6):413-26
pubmed: 17514195
Front Neural Circuits. 2019 Dec 05;13:78
pubmed: 31866835
Brain Res. 1990 Oct 22;530(2):345-8
pubmed: 2176121
J Sex Med. 2009 Jun;6(6):1506-1533
pubmed: 19453889
Prog Neurobiol. 2001 Feb;63(3):241-320
pubmed: 11115727
Psychopharmacology (Berl). 2014 Oct;231(20):4071-80
pubmed: 24671517
Nat Neurosci. 2003 Sep;6(9):968-73
pubmed: 12897785
J Biol Chem. 1951 Nov;193(1):265-75
pubmed: 14907713